TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07507422: Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy

Sponsor: Medtronic · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 970 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07507422 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07507422 Rescue Dossier →